NR3C2 and metabolic dysfunction-associated steatotic liver disease: Spironolactone, a potassium-sparing diuretic and mineralocorticoid receptor antagonist, is commonly used to manage a range of conditions, including cirrhosis [29], non-alcoholic fatty liver disease [30], polycystic ovary syndrome [31], diabetic nephropathy [32], and hypertension [33].